川宁生物：8月22日召开董事会会议

Group 1 - The core viewpoint of the article highlights that Chuaning Bio (SZ 301301) held its 11th meeting of the second board session on August 22, 2025, to review proposals regarding the revision and establishment of certain internal systems [1] - For the fiscal year 2024, Chuaning Bio's revenue composition is reported as 93.72% from the pharmaceutical manufacturing sector and 6.28% from other businesses [1] - As of the report date, Chuaning Bio has a market capitalization of 28.4 billion yuan [1] Group 2 - The article also notes that the A-share market has seen trading volumes exceed 20 trillion yuan for eight consecutive days, indicating a robust trading environment [1] - Major industry players are actively recruiting for autumn positions, with 25 job roles highlighted, reflecting a demand for talent in the sector [1]